Edwards Lifesciences Corp (EW) income statement
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$105.23−0.20 (-0.19%)
Close on Nov 18, 2026Market cap $60.65BP/E 60.5Yield –
Edwards Lifesciences Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 77.8%
- Operating margin
- 22.3%
- Net margin
- 15.4%
- Return on equity, FY2025
- 10.6%
Financial strength
- Current ratio
- 4.52
- Debt to equity
- 0.06
- Debt to assets
- 4.3%
- Cash to current liabilities
- 192.8%
Valuation
- P/E ratio
- 60.5
- Price to sales
- 9.31
- Price to book
- 5.71
- Dividend yield
- –
See a number that looks wrong?